Dale Ando

8.1k citations

55 papers · 5.4k indexed · 2 hit papers · h-index 30

Immunology top 1%
- Immunotherapy and Immune Responses 14
- T-cell and B-cell Immunology 8
- Immune Cell Function and Interaction 7
Business and International Management top 1%
Virology top 2%
Genetics top 1%
- Virus-based gene therapy research 21
Oncology top 2%
- CAR-T cell therapy research 10
Molecular Biology
- CRISPR and Genetic Engineering 12
- RNA Interference and Gene Delivery 7
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 8

Co-authors: Eli E. Sercarz Julie Clayton J L Urban Dwight H. Kono Michael C. Holmes Philip D. Gregory D H Kono Leroy Hood
Cited by: Immunology Business and International Management Virology
Journals: Molecular Therapy (6 papers)Blood (6 papers)Cancer Gene Therapy (3 papers)
Partner nations: United States Canada Italy

In The Last Decade

Dale Ando

55 papers receiving 5.2k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Dale Ando

Since Specialization

Citations

This map shows the geographic impact of Dale Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dale Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dale Ando more than expected).

Fields of papers citing papers by Dale Ando

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dale Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dale Ando. The network helps show where Dale Ando may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dale Ando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dale Ando Line = papers co-authored together Dale Ando links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Gene Editing Hematology/Oncology Clinics of North America ·Dale Ando,Kathleen Meyer	2017	7
2	Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIVbreakdown → New England Journal of Medicine ·Pablo Tebas,David Stein,Winson W. Tang,Ian Frank,Paul Avenant,Gary Lee,S. Kaye Spratt,Richard Surosky,Martin Giedlin,Geoff Nichol,Michael C. Holmes,Philip D. Gregory,Dale Ando,Michael Kalos,Ronald G. Collman,Gwendolyn Binder-Scholl,Gabriela Plesa,Wei‐Ting Hwang,Bruce L. Levine,Carl H. June	2014	973
3	Delayed Administration of a Bio-Engineered Zinc-Finger VEGF-A Gene Therapy Is Neuroprotective and Attenuates Allodynia Following Traumatic Spinal Cord Injury PLoS ONE ·Sarah A. Figley,Yang Liu,Spyridon K. Karadimas,Kajana Satkunendrarajah,Peter Fettes,S. Kaye Spratt,Gary Lee,Dale Ando,Richard Surosky,Martin Giedlin,Michael G. Fehlings	2014	31
4	Efficient Clinical Scale Gene Modification via Zinc Finger Nuclease–Targeted Disruption of the HIV Co-receptor CCR5 Human Gene Therapy ·C.A. Madramootoo,Andrea Brennan,Shuguang Jiang,Gwendolyn Binder-Scholl,Gary Lee,Gabriela Plesa,Zhaohui Zheng,Julio Cotte,Carmine Carpenito,Maxim Averbukh,S. Kaye Spratt,Dale Ando,Philip D. Gregory,Michael C. Holmes,Elena Pérez,James L. Riley,Richard G. Carroll,Carl H. June,Bruce L. Levine	2013	91
5	An engineered transcription factor which activates VEGF-A enhances recovery after spinal cord injury Neurobiology of Disease ·Yang Liu,Sarah A. Figley,S. Kaye Spratt,Gary Lee,Dale Ando,Richard Surosky,Michael G. Fehlings	2009	71
6	Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector deliverybreakdown → Nature Biotechnology ·Angelo Lombardo,Pietro Genovese,Christian Beauséjour,Silvia Colleoni,好信小林,Anne Jobling,Dale Ando,Fyodor D. Urnov,Cesare Galli,Philip D. Gregory,Michael C. Holmes,Luigi Naldini	2007	647
7	A Phase I Trial of Intravenous CG7870, a Replication-Selective, Prostate-Specific Antigen–Targeted Oncolytic Adenovirus, for the Treatment of Hormone-Refractory, Metastatic Prostate Cancer Molecular Therapy ·Eric J. Small,Michael A. Carducci,James M. Burke,Ron Rodriguez,Lawrence Fong,Lynn Van Ummersen,Dechao Yu,Junko Aimi,Dale Ando,Peter K. Working,David H. Kirn,George Wilding	2006	185
8	Advanced renal cell carcinoma treated with granulocyte‐macrophage colony‐stimulating factor gene therapy: A clinical course of the first Japanese experience International Journal of Urology ·Koji Kawai,Kenzaburo Tani,Naohide Yamashita,Shinji Tomikawa,Masazumi Eriguchi,Μakoto Fujime,Ko Okumura,Tadao Kakizoe,Gerson Mazzaferro Silveira,Dale Ando,Richard C. Mulligan,Andreas Wähnert,Masayuki Noguchi,Shigetaka Asano,Hideyuki Akaza	2002	7
9	Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies Cancer Chemotherapy and Pharmacology ·William G. Nelson,Jonathan W. Simons,Bahar Mikhak,S.A. van de Graaf,Angelo M. De Marzo,Philip Hoog,Michael Kim,HU Guang-fu,Angelo A. Baccala,Alexandr Nikolaevich Yavorsky,S Clift,Dale Ando,Hyam I. Levitsky,L. Cohen,Martin G. Sanda,Richard C. Mulligan,Alan W. Partin,H. Ballentine Carter,Y.C.Yang,Fray F. Marshall	2000	62
10	Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-γ retroviral vector in melanoma patients Cancer Gene Therapy ·Shigeyuki Fujii,Sharon K. Huang,Melanio Seduripa Figuracion,Dale Ando,Francis Burrows,Douglas J. Jolly,John Nemunaitis,Dave S.�B. Hoon	2000	33
11	Phase I trial of interferon-γ (IFN-γ) retroviral vector administered intratumorally to patients with metastatic melanoma Cancer Gene Therapy ·John Nemunaitis,Timothy Fong,Joan M. Robbins,Gerald M. Edelman,Wilson B. Edwards,耿文欣,久志大槻,Bengüsü Hazal Abacıoğlu,Dee Wynne,Marilyn C. Pike,Микола Вікторович Біба,James A. Merritt,Dale Ando	1999	39
12	Phase I Trial of Interferon gamma Retroviral Vector Administered Intratumorally with Multiple Courses in Patients with Metastatic Melanoma Human Gene Therapy ·John Nemunaitis,Timothy Fong,Francis Burrows,久志大槻,Xuejuan Cheng,Bengüsü Hazal Abacıoğlu,Wally Meyer,Dee Wynne,Edwin D. Ibañez,John Pippen,F. B. Oldham,Dale Ando	1999	39
13	Antifungal Activity of Recombinant Human Macrophage Colony-Stimulating Factor in Models of Acute and Chronic Candidiasis in the Rat The Journal of Infectious Diseases ·C R Vitt,John M. Fidler,Dale Ando,Robert J. Zimmerman,Mathias Haubjerg	1994	30
14	Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proceedings of the National Academy of Sciences ·J E Merrill,D H Kono,John L. Clayton,Dale Ando,David R. Hinton,Florence M. Hofman	1992	260
15	Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. The Journal of Experimental Medicine ·Julie Clayton,Marisa Villagomez Izaguirre,Dale Ando,D H Kono,Leroy Hood,Eli E. Sercarz	1989	136
16	Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype Cellular Immunology ·Dale Ando,Julie Clayton,Dwight H. Kono,J L Urban,Eli E. Sercarz	1989	326
17	T cell up-regulation of B cells via their idiotypes contributing to the development of systemic lupus erythematosus The American Journal of Medicine ·Bevra H. Hahn,Dale Ando,Fanny M. Ebling,Marek Podkowski,Betty P. Tsao,Kenneth Kalunian	1988	3
18	Idiotypic spreading promotes the production of pathogenic autoantibodies Journal of Autoimmunity ·Fanny M. Ebling,Dale Ando,Marek Podkowski,Kenneth Kalunian,Bevra H. Hahn	1988	16
19	Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy Cell ·J L Urban,Vipin Kumar,Dwight H. Kono,Christopher M. Gómez,Suzanna J. Horvath,Julie Clayton,Dale Ando,Eli E. Sercarz,Leroy Hood	1988	492
20	Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus The American Journal of Medicine ·Kenneth Kalunian,Holly R. Middlekauff,James Sayre,Dale Ando,Maureen Mangotich,Bevra H. Hahn,James B. Peter	1988	132

About Dale Ando

Dale Ando is a scholar working on Immunology, Virology and Genetics, having authored 55 papers that have together received 5.4k indexed citations. Recurring topics across this work include Virus-based gene therapy research (21 papers), Immunotherapy and Immune Responses (14 papers), CRISPR and Genetic Engineering (12 papers), CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), T-cell and B-cell Immunology (8 papers), RNA Interference and Gene Delivery (7 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Immunology (2.3k citations), Business and International Management (151 citations) and Virology (360 citations). Dale Ando has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Eli E. Sercarz, Julie Clayton, J L Urban, Dwight H. Kono, Michael C. Holmes, Philip D. Gregory, D H Kono, Leroy Hood, Suzanna J. Horvath and Gary Lee. Their work appears in journals such as Molecular Therapy, Blood, Cancer Gene Therapy, The Journal of Immunology and The American Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact